70
Views
15
CrossRef citations to date
0
Altmetric
Original Article: Clinical

Antiangiogenic activity of thalidomide in combination with fludarabine, carboplatin, and topotecan for high-risk acute myelogenous leukemia

, , , , , , , , , , & show all
Pages 1940-1949 | Received 13 Mar 2007, Accepted 09 Jul 2007, Published online: 01 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Massimo Breccia & Giuliana Alimena. (2010) NF-κB as a potential therapeutic target in myelodysplastic syndromes and acute myeloid leukemia. Expert Opinion on Therapeutic Targets 14:11, pages 1157-1176.
Read now
Camilla Stapnes, Bjørn Tore Gjertsen, Håkon Reikvam & Øystein Bruserud. (2009) Targeted therapy in acute myeloid leukaemia: current status and future directions. Expert Opinion on Investigational Drugs 18:4, pages 433-455.
Read now

Articles from other publishers (13)

Ahmed Ismail Eatmann, Esraa Hamouda, Heba Hamouda, Hossam Khaled Farouk, Afnan W. M. Jobran, Abdallah A. Omar, Alyaa Khaled Madeeh, Nada Mostafa Al-dardery, Salma Elnoamany, Eman Gamal Abd-Elnasser, Abdullah Muhammed Koraiem, Alhassan Ali Ahmed, Mohamed Abouzid & Marta Karaźniewicz-Łada. (2023) Potential Use of Thalidomide in Glioblastoma Treatment: An Updated Brief Overview. Metabolites 13:4, pages 543.
Crossref
Vanessa Desantis, Aurelia Lamanuzzi, Ilaria Saltarella, Maria Antonia Frassanito, Angelo Vacca, Monica Montagnani & Domenico Ribatti. 2022. Antiangiogenic Drugs as Chemosensitizers in Cancer Therapy. Antiangiogenic Drugs as Chemosensitizers in Cancer Therapy 111 125 .
Seyma Aydinlik, Ayca Uvez, Hulya Tuba Kiyan, Ebru Gurel-Gurevin, Veysel Turan Yilmaz, Engin Ulukaya & Elif Ilkay Armutak. (2021) Palladium (II) complex and thalidomide intercept angiogenic signaling via targeting FAK/Src and Erk/Akt/PLCγ dependent autophagy pathways in human umbilical vein endothelial cells. Microvascular Research 138, pages 104229.
Crossref
Antonio Piccolomo, Claudia Pia Schifone, Vanda Strafella, Giorgina Specchia, Pellegrino Musto & Francesco Albano. (2020) Immunomodulatory Drugs in Acute Myeloid Leukemia Treatment. Cancers 12:9, pages 2528.
Crossref
Kazusa Ishii & Austin J. Barrett. (2015) Novel immunotherapeutic approaches for the treatment of acute leukemia (myeloid and lymphoblastic). Therapeutic Advances in Hematology 7:1, pages 17-39.
Crossref
Domenico Ribatti. (2013) Angiogenesis as a treatment target in leukemia. International Journal of Hematologic Oncology 2:3, pages 229-242.
Crossref
GUANHUA SONG, YANMEI LI & GUOSHENG JIANG. (2012) Role of VEGF/VEGFR in the pathogenesis of leukemias and as treatment targets (Review). Oncology Reports 28:6, pages 1935-1944.
Crossref
Jennifer Kendrick, Dawn Warkentin & Mary H. H. Ensom. 2012. Energy Balance and Hematologic Malignancies. Energy Balance and Hematologic Malignancies 97 127 .
Waqas Rehman, Lisa M. Arfons & Hillard M. Lazarus. (2011) The rise, fall and subsequent triumph of thalidomide: lessons learned in drug development. Therapeutic Advances in Hematology 2:5, pages 291-308.
Crossref
Willem J. van Heeckeren, Pingfu Fu, Paul M. Barr, Lisa M. Arfons, Mark H. Kirschbaum, Hillard M. Lazarus & Brenda W. Cooper. (2011) Safety and tolerability of phase I/II clinical trials among older and younger patients with acute myelogenous leukemia. Journal of Geriatric Oncology 2:3, pages 215-221.
Crossref
Rajeev S. Samant & Lalita A. Shevde. (2011) Recent Advances in Anti-Angiogenic Therapy of Cancer. Oncotarget 2:3, pages 122-134.
Crossref
Michael Medinger, Natalie Fischer & Alexandar Tzankov. (2010) Vascular Endothelial Growth Factor-Related Pathways in Hemato-Lymphoid Malignancies. Journal of Oncology 2010, pages 1-13.
Crossref
William W. Li, Michelle Hutnik & Gerald Gehr. (2008) Antiangiogenesis in haematological malignancies. British Journal of Haematology 143:5, pages 622-631.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.